Redwood City, CA, United States of America

Luis G Borges

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Luis G Borges

Introduction

Luis G Borges is an accomplished inventor based in Redwood City, California, credited with two significant patents in the field of biotechnology. His work primarily focuses on the development of bispecific antibodies and other related molecules, which have considerable implications in the field of immunotherapy.

Latest Patents

Luis G Borges holds two notable patents:

1. **Bispecific-Fc Molecules** - This patent describes a bispecific molecule comprising an Fc polypeptide chain and immunoglobulin variable regions. The invention also details pharmaceutical formulations that contain these molecules, nucleic acids encoding them, host cells incorporating such nucleic acids, methods for their production, and applications for their use.

2. **Heterodimeric Bispecific Antibodies** - This innovation involves heterodimeric bispecific antibodies capable of mediating the cytolysis of target cells by immune effector cells. The patent includes details about nucleic acids that encode these antibodies, methods for their creation, and applications utilizing these antibodies, which consist of two different polypeptide chains, each containing two immunoglobulin variable regions and potentially a half-life-extending moiety.

Career Highlights

Luis G Borges has established himself as a key figure in the biopharmaceutical industry while working at Amgen Inc., a global leader in biotechnology innovation. His contributions have played a vital role in advancing therapeutic options for patients, particularly in the realms of cancer treatment and autoimmune diseases.

Collaborations

Throughout his career, Luis has collaborated with notable colleagues such as Wei Yan and Mark Leo Michaels. These collaborations have not only enhanced his research but also fostered a synergetic approach to developing new therapeutic solutions.

Conclusion

Luis G Borges continues to push the boundaries of scientific innovation through his patents and collaborative work. His contributions to bispecific antibodies and related biotechnologies signify a remarkable leap forward in the treatment protocols available in modern medicine. As the field evolves, his ongoing research and inventions hold great promise for future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…